Works matching MGMT

Results: 2936

Prognostic significance of MGMT methylation and expression of MGMT, P53, EGFR, MDM2 and PTEN in glioblastoma multiforme.

Published in:

Annales de Biologie Clinique, 2019, v. 77, n. 3, p. 307, doi. 10.1684/abc.2019.1448

By:

Limam, Sarra;
Missaoui, Nabiha;
Abdessayed, Nihed;
Mestiri, Sarra;
Selmi, Boulbaba;
Mokni, Moncef;
Yacoubi, Mohamed Tahar

Publication type:

Article

The Potential Effect of the IDH1 Mutation and MGMT Gene Promoter Methylation on the Control of Glioblastoma-Associated Epilepsy in Patients Receiving Anti-Epileptic Agents and Chemotherapies.

Published in:

Archives of Epilepsy, 2021, v. 27, n. 3, p. 155, doi. 10.14744/epilepsi.2021.71676

By:

KURDI, Maher;
BUTT, Nadeem Shafique;
BAEESA, Saleh;
ALGHAMDI, Badrah;
MAGHRABI, Yazid;
BARDEESI, Anas;
SAEEDI, Rothaina;
ALGHAMDI, Fahad;
ALGHANMI, Najla;
BARI, Mohammed;
SAMKARI, Alaa;
LARY, Ahmed;
ALSINANI, Taghreed;
HAKAMY, Sahar

Publication type:

Article

黄芩素通过调控Wnt/β-catenin信号通路抑制人胶质母细胞瘤细胞MGMT表达.

Published in:

Progress in Modern Biomedicine, 2018, v. 18, n. 8, p. 1414, doi. 10.13241/j.cnki.pmb.2018.08.003

By:

卫翔宇;
陈正;
沈霖;
李世亭;
郑学胜

Publication type:

Article

异柠檬酸脱氢酶-1 突变及MGMT 甲基化在脑胶质瘤的诊断及治疗研究进展.

Published in:

Progress in Modern Biomedicine, 2016, v. 16, n. 5, p. 970, doi. 10.13241/j.cnki.pmb.2016.05.044

By:

蒋梦婉;
刘琪;
李嘉瑶;
董祥慧;
董祥慧戚基萍

Publication type:

Article

MGMT启动子甲基化在接受放化疗的新发野生型胶质母细胞瘤患者中的预后作用.

Published in:

Journal of Clinical Neurosurgery / Linchuang Shenjingwaike Zazhi, 2024, v. 21, n. 2, p. 182, doi. 10.3969/m.1672-7770.2004.02.012

By:

古威开;
李晨曦;
陈小红;
苏丽萍;
郑亚杰

Publication type:

Article

基于 CRISPR-Cas12a 检测成人型弥漫性胶质瘤 MGMT 启动子甲基化.

Published in:

Journal of Clinical Neurosurgery / Linchuang Shenjingwaike Zazhi, 2023, v. 20, n. 6, p. 664, doi. 10.3969/j.issn.1672-7770.2023.06.012

By:

冯哲斌;
孔东生;
许军鹏;
武其嘉;
张宇;
余新光;
冯世宇

Publication type:

Article

室管膜下区相关 IDH 野生型胶质母细胞瘤: MGMT 甲基化特征及生存预后分析.

Published in:

Journal of Clinical Neurosurgery / Linchuang Shenjingwaike Zazhi, 2022, v. 19, n. 6, p. 661, doi. 10.3969/j.issn.1672-7770.2022.06.011

By:

刘若愚;
赵恺;
刘明航;
赵悦;
攸娜;
伊柯机;
孙国臣

Publication type:

Article

miR-1197抑制MGMT表达对胶质瘤替莫唑胺耐药性的影响.

Published in:

Journal of Clinical Neurosurgery / Linchuang Shenjingwaike Zazhi, 2020, v. 17, n. 6, p. 645, doi. 10.3969/j.issn.1672-7770.2020.06.010

By:

聂耳;
石秦宇;
韩正中;
张旭;
苗发安

Publication type:

Article

TERTp 和 1p/19q 对顺铂联合替莫唑胺同期放化疗治疗 MGMT 启动子未甲基化 GBM 的预后影响

Published in:

Journal of Clinical Neurosurgery / Linchuang Shenjingwaike Zazhi, 2019, v. 16, n. 4, p. 289, doi. 10.3969/j.issn.1672-7770.2019.04.003

By:

高洪元;
张玺炜;
汪洋;
盛晓芳;
吴学勇;
殷晓峰;
陈淑;
倪春霞;
孟歌;
胡莉，;
王宝

Publication type:

Article

Novel MGMT inhibitors increase the sensitivity of glioma MGMT-positive cells to treatment with alkylating agents in vitro.

Published in:

Biopolymers & Cell, 2024, v. 40, n. 1, p. 47, doi. 10.7124/bc.000AAD

By:

Zhuvaka, K. S.;
Piven, O. О.;
Macewicz, L. L.;
Ruban, T. P.;
Volynets, G. P.;
Yarmoluk, S. M.;
Dobrzyn, P.;
Lukash, L. L.

Publication type:

Article

MGMT、XRCC1 基因在脑胶质瘤中的表达及其临床应用.

Published in:

Journal of Kunming Medical University / Kunming Yike Daxue Xuebao, 2015, v. 36, n. 12, p. 112

By:

王参智;
罗林

Publication type:

Article

临床研究. MGMT基因启动子甲基化与非小细胞肺癌关系的meta分析.

Published in:

Chinese Journal of Lung Cancer, 2014, v. 17, n. 8, p. 601, doi. 10.3779/j.issn.1009-3419.2014.08.04

By:

房念珍;
谷俊东;
魏慧君;
尤嘉琮;
周清华

Publication type:

Article

Research on DNA methylation of human osteosarcoma cell MGMT and its relationship with cell resistance to alkylating agents.

Published in:

Biochemistry & Cell Biology, 2013, v. 91, n. 4, p. 209, doi. 10.1139/bcb-2012-0100

By:

Guo, Jun;
Cui, Qiu;
Jiang, WeiHao;
Liu, Cheng;
Li, DingFeng;
Zeng, Yanjun

Publication type:

Article

Optimizing conditions for MGMT promoter methylation status analysis in glioblastoma FFPE samples.

Published in:

Biologica Nyssana, 2020, v. 11, n. 2, p. 139, doi. 10.5281/zenodo.4393973

By:

Jovanović, Nikola M.;
Nikolov, Vesna;
Vidović, Nataša;
Vitorović, Jelena;
Tošić, Svetlana;
Cvetković, Vladimir J.;
Mitrović, Tatjana;
Jevtović-Stoimenov, Tatjana

Publication type:

Article

Intérêt du statut MGMT comme aide décisionnelle au choix de la chimiothérapie des tumeurs neuroendocrines.

Published in:

Hépato-Gastro & Oncologie Digestive, 2024, v. 31, n. 5, p. 438, doi. 10.1684/hpg.2024.2761

By:

Durand, Alice;
Walter, Thomas

Publication type:

Article

Chemoproteomik-vermittelte Entdeckung eines potenten und selektiven Inhibitors des DNA-Reparaturproteins MGMT.

Published in:

Angewandte Chemie, 2016, v. 128, n. 8, p. 2964, doi. 10.1002/ange.201511301

By:

Wang, Chao;
Abegg, Daniel;
Hoch, Dominic G.;
Adibekian, Alexander

Publication type:

Article

Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma.

Published in:

Egyptian Journal of Medical Human Genetics, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s43042-024-00516-3

By:

Mahmoud, Magda Sayed;
Khalifa, Mohamed K.;
Nageeb, Amira M.;
El-Arab, Lobna R. Ezz;
El-Mahdy, Manal;
Ramadan, Amal;
Hashim, Maha;
Bakr, Noha M.;
Swellam, Menha

Publication type:

Article

Effect of segmentation dimension on radiomics analysis for MGMT promoter methylation status in gliomas.

Published in:

Current Neurology / Aktualno?ci Neurologiczne, 2024, v. 24, n. 1, p. 8, doi. 10.15557/AN.2024.0002

By:

Ryohei Fukui;
Masataka Onishi;
Koshi Hasegawa;
Miyu Ohata;
Katsuhiro Kida;
Sachiko Goto

Publication type:

Article

MGMT expression and promoter methylation status may depend on the site of surgical sample collection within glioblastoma: a possible pitfall in stratification of patients?

Published in:

Journal of Neuro-Oncology, 2012, v. 106, n. 1, p. 33, doi. 10.1007/s11060-011-0639-9

By:

Della Puppa, Alessandro;
Persano, Luca;
Masi, Giulia;
Rampazzo, Elena;
Sinigaglia, Alessandro;
Pistollato, Francesca;
Denaro, Luca;
Barzon, Luisa;
Palù, Giorgio;
Basso, Giuseppe;
Scienza, Renato;
d'Avella, Domenico

Publication type:

Article

MGMT promoter methylation and immunoexpression in aggressive pituitary adenomas and carcinomas.

Published in:

Journal of Neuro-Oncology, 2011, v. 104, n. 3, p. 647, doi. 10.1007/s11060-011-0532-6

By:

Salehi, Fateme;
Scheithauer, Bernd;
Kros, Johann;
Lau, Queenie;
Fealey, Michael;
Erickson, Dana;
Kovacs, Kalman;
Horvath, Eva;
Lloyd, Ricardo

Publication type:

Article

MGMT methylation and its prognostic significance in inoperable IDH-wildtype glioblastoma: the MGMT-GBM study.

Published in:

Acta Neurochirurgica, 2024, v. 166, n. 1, p. 1, doi. 10.1007/s00701-024-06300-x

By:

Ghimire, Prajwal;
Kamaludin, Ahmad;
Palau, Berta F.;
Lavrador, Jose P.;
Gullan, Richard;
Vergani, Francesco;
Bhangoo, Ranjeev;
Ashkan, Keyoumars

Publication type:

Article

Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide.

Published in:

2010

By:

van Nifterik, K. A.;
van den Berg, J.;
van der Meide, W. F.;
Ameziane, N.;
Wedekind, L. E.;
Steenbergen, R. D. M.;
Leenstra, S.;
Lafleur, M. V. M.;
Slotman, B. J.;
Stalpers, L. J. A.;
Sminia, P.

Publication type:

journal article

Association between MGMT Enhancer Methylation and MGMT Promoter Methylation, MGMT Protein Expression, and Overall Survival in Glioblastoma.

Published in:

Cells (2073-4409), 2023, v. 12, n. 12, p. 1639, doi. 10.3390/cells12121639

By:

Zappe, Katja;
Pühringer, Katharina;
Pflug, Simon;
Berger, Daniel;
Böhm, Andreas;
Spiegl-Kreinecker, Sabine;
Cichna-Markl, Margit

Publication type:

Article

QSAR and Chemical Read-Across Analysis of 370 Potential MGMT Inactivators to Identify the Structural Features Influencing Inactivation Potency.

Published in:

Pharmaceutics, 2023, v. 15, n. 8, p. 2170, doi. 10.3390/pharmaceutics15082170

By:

Sun, Guohui;
Bai, Peiying;
Fan, Tengjiao;
Zhao, Lijiao;
Zhong, Rugang;
McElhinney, R. Stanley;
McMurry, T. Brian H.;
Donnelly, Dorothy J.;
McCormick, Joan E.;
Kelly, Jane;
Margison, Geoffrey P.

Publication type:

Article

New insights into estrogenic regulation of O6-methylguanine DNA-methyltransferase (MGMT) in human breast cancer cells: Co-degradation of ER-α and MGMT proteins by fulvestrant or O6-benzylguanine indicates fresh avenues for therapy.

Published in:

Journal of Biomedical Research, 2016, v. 30, n. 5, p. 393, doi. 10.7555/JBR.30.20160040

By:

Paranjpe, Ameya;
Bailey, Nathan I.;
Yusuf, Mohd. A.;
Punganuru, Surendra R.;
Madala, Hanumantha Rao;
Basak, Debasish;
Mostofa, A. G. M.;
Srivenugopal, Kalkunte S.;
Konduri, Santhi;
Bobustuc, George C.;
Ali-Osman, Francis

Publication type:

Article

MGMT and SPOCK2 Promoter Methylation in Diffuse Large B-Cell Lymphoma: A Study in Two Tertiary Health Centres in the East Coast of Malaysia.

Published in:

Malaysian Journal of Health Sciences / Jurnal Sains Kesihatan Malaysia, 2017, v. 15, n. 2, p. 77, doi. 10.17576/JSKM-2017-1502-10

By:

ZAINUDDIN, NORAFIZA;
MOHD RIDAH, LAILATUL JALILAH;
OMAR, AQILAH NABIHAH;
TALIB, NORLELAWATI A.;
MUHAMMAD, NAZNIN;
HUSSAIN, FAEZAHTUL ARBAEYAH

Publication type:

Article

MGMT ProFWise: Unlocking a New Application for Combined Feature Selection and the Rank-Based Weighting Method to Link MGMT Methylation Status to Serum Protein Expression in Patients with Glioblastoma.

Published in:

International Journal of Molecular Sciences, 2024, v. 25, n. 7, p. 4082, doi. 10.3390/ijms25074082

By:

Tasci, Erdal;
Shah, Yajas;
Jagasia, Sarisha;
Zhuge, Ying;
Shephard, Jason;
Johnson, Margaret O.;
Elemento, Olivier;
Joyce, Thomas;
Chappidi, Shreya;
Cooley Zgela, Theresa;
Sproull, Mary;
Mackey, Megan;
Camphausen, Kevin;
Krauze, Andra Valentina

Publication type:

Article

Less Severe Polymicrobial Sepsis in Conditional mgmt -Deleted Mice Using LysM-Cre System, Impacts of DNA Methylation and MGMT Inhibitor in Sepsis.

Published in:

International Journal of Molecular Sciences, 2023, v. 24, n. 12, p. 10175, doi. 10.3390/ijms241210175

By:

Sae-khow, Kritsanawan;
Phuengmaung, Pornpimol;
Issara-Amphorn, Jiraphorn;
Makjaroen, Jiradej;
Visitchanakun, Peerapat;
Boonmee, Atsadang;
Benjaskulluecha, Salisa;
Palaga, Tanapat;
Leelahavanichkul, Asada

Publication type:

Article

Influence of MMR, MGMT Promotor Methylation and Protein Expression on Overall and Progression-Free Survival in Primary Glioblastoma Patients Treated with Temozolomide.

Published in:

International Journal of Molecular Sciences, 2023, v. 24, n. 7, p. 6184, doi. 10.3390/ijms24076184

By:

Brawanski, Konstantin R.;
Sprung, Susanne;
Freyschlag, Christian F.;
Hoeftberger, Romana;
Ströbel, Thomas;
Haybaeck, Johannes;
Thomé, Claudius;
Manzl, Claudia;
Birkl-Toeglhofer, Anna M.

Publication type:

Article

Combination chemotherapy versus temozolomide for patients with methylated MGMT (m-MGMT) glioblastoma: results of computational biological modeling to predict the magnitude of treatment benefit.

Published in:

Journal of Neuro-Oncology, 2021, v. 153, n. 3, p. 393, doi. 10.1007/s11060-021-03780-0

By:

Castro, Michael;
Pampana, Anusha;
Alam, Aftab;
Parashar, Rajan;
Rajagopalan, Swaminathan;
Lala, Deepak Anil;
Roy, Kunal Ghosh Ghosh;
Basu, Sayani;
Prakash, Annapoorna;
Nair, Prashant;
Joseph, Vishwas;
Agarwal, Ashish;
G, Poornachandra;
Behura, Liptimayee;
Kulkarni, Shruthi;
Choudhary, Nikita Ray;
Kapoor, Shweta

Publication type:

Article

Analysis of MGMT promoter methylation status on intraoperative fresh tissue section from frameless neuronavigation needle biopsy: a preliminary study of ten patients.

Published in:

Acta Neurochirurgica, 2010, v. 152, n. 7, p. 1189, doi. 10.1007/s00701-010-0639-0

By:

Iaccarino, Corrado;
Nicoli, Davide;
Gallo, Carmine;
Nasi, Davide;
Pisanello, Anna;
Berti, Gianni;
Ghadirpour, Reza;
Marcello, Norina;
Servadei, Franco

Publication type:

Article

Promoter Methylation and Polymorphisms of the MGMT Gene in Glioblastomas: A Population-Based Study.

Published in:

Neuroepidemiology, 2009, v. 32, n. 1, p. 21, doi. 10.1159/000170088

By:

Zawlik, Izabela;
Vaccarella, Salvatore;
Kita, Daisuke;
Mittelbronn, Michel;
Franceschi, Silvia;
Ohgaki, Hiroko

Publication type:

Article

A "Clickable" Probe for Active MGMT in Glioblastoma Demonstrates Two Discrete Populations of MGMT.

Published in:

Cancers, 2020, v. 12, n. 2, p. 453, doi. 10.3390/cancers12020453

By:

Raghavan, Sudhir;
Baskin, David S.;
Sharpe, Martyn A.

Publication type:

Article

Rare Stochastic Expression of O6-Methylguanine- DNA Methyltransferase (MGMT) in MGMT-Negative Melanoma Cells Determines Immediate Emergence of Drug-Resistant Populations upon Treatment with Temozolomide In Vitro and In Vivo.

Published in:

Cancers, 2018, v. 10, n. 10, p. 362, doi. 10.3390/cancers10100362

By:

Chen, Thomas C.;
Chan, Nymph;
Minea, Radu O.;
Hartman, Hannah;
Hofman, Florence M.;
Schönthal, Axel H.

Publication type:

Article

Do we really know who has an MGMT methylated glioma? Results of an international survey regarding use of MGMT analyses for glioma.

Published in:

Neuro-Oncology Practice, 2020, v. 7, n. 1, p. 68, doi. 10.1093/nop/npz039

By:

Malmström, Annika;
Łysiak, Małgorzata;
Kristensen, Bjarne Winther;
Hovey, Elizabeth;
Henriksson, Roger;
Söderkvist, Peter

Publication type:

Article

Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma.

Published in:

BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-511

By:

Oliver, Jaime Antonio;
Ortiz, Raúl;
Melguizo, Consolación;
Álvarez, Pablo Juan;
Gómez-Millán, Jaime;
Prados, Jose

Publication type:

Article

Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma

Published in:

BMC Cancer, 2014, v. 14, n. 1, p. 511, doi. 10.1186/1471-2407-14-511

By:

Oliver, Jaime Antonio;
Ortiz, Raúl;
Melguizo, Consolación;
Álvarez, Pablo Juan;
Gómez-Millán, Jaime;
Prados, Jose

Publication type:

Article

Correlation of apparent diffusion coefficient values measured by diffusion MRI and MGMT promoter methylation semiquantitatively analyzed with MS-MLPA in patients with glioblastoma multiforme.

Published in:

Journal of Magnetic Resonance Imaging, 2013, v. 37, n. 2, p. 351, doi. 10.1002/jmri.23838

By:

Sunwoo, Leonard;
Choi, Seung Hong;
Park, Chul ‐ Kee;
Kim, Jin Wook;
Yi, Kyung Sik;
Lee, Woong Jae;
Yoon, Tae Jin;
Song, Sang Woo;
Kim, Ja Eun;
Kim, Ji Young;
Kim, Tae Min;
Lee, Se ‐ Hoon;
Kim, Ji ‐ Hoon;
Sohn, Chul ‐ Ho;
Park, Sung ‐ Hye;
Kim, Il Han;
Chang, Kee ‐ Hyun

Publication type:

Article

Evaluation status and prognostic significance of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation in pediatric high grade gliomas.

Published in:

Child's Nervous System, 2010, v. 26, n. 8, p. 1051, doi. 10.1007/s00381-010-1191-1

By:

Buttarelli, Francesca R.;
Massimino, Maura;
Antonelli, Manila;
Lauriola, Libero;
Nozza, Paolo;
Donofrio, Vittoria;
Arcella, Antonella;
Oliva, Maria A.;
Di Rocco, Concezio;
Giangaspero, Felice

Publication type:

Article

MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy.

Published in:

Journal of Translational Medicine, 2012, v. 10, n. 1, p. 250, doi. 10.1186/1479-5876-10-250

By:

Melguizo, Consolaci¢n;
Prados, Jose;
Gonz lez, Beatriz;
Ortiz, Raul;
Concha, Angel;
Alvarez, Pablo Juan;
Madeddu, Roberto;
Perazzoli, Gloria;
Oliver, Jaime Antonio;
L¢pez, Rodrigo;
Rodr¡guez-Serrano, Fernando;
Ar nega, Antonia

Publication type:

Article

Association of Intergenic and Intragenic MGMT Enhancer Methylation with MGMT Promoter Methylation, MGMT Protein Expression and Clinical and Demographic Parameters in Glioblastoma.

Published in:

International Journal of Molecular Sciences, 2025, v. 26, n. 7, p. 3390, doi. 10.3390/ijms26073390

By:

Pühringer, Katharina;
Czarda, Philipp;
Iluca, Sebastian;
Zappe, Katja;
Weis, Serge;
Spiegl-Kreinecker, Sabine;
Cichna-Markl, Margit

Publication type:

Article

A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM].

Published in:

BMC Neurology, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12883-024-03605-3

By:

Gibson, David;
Vo, Anh Huan;
Lambing, Hannah;
Bhattacharya, Prithanjan;
Tahir, Peggy;
Chehab, Farid F.;
Butowski, Nicholas

Publication type:

Article

Mutational-reporter transgenes rescued from mice lacking either Mgmt, or both Mgmt and Msh6 suggest that O6-alkylguanine-induced miscoding does not contribute to the spontaneous mutational spectrum.

Published in:

Oncogene, 2004, v. 23, n. 35, p. 5931, doi. 10.1038/sj.onc.1207791

By:

Sandercock, Linda E.;
Kwok, Melvin C. H.;
Luchman, H. Artee;
Mark, Sean C.;
Giesbrecht, Jennette L.;
Samson, Leona D.;
Jirik, Frank R.

Publication type:

Article

Inhibition of O6‐methylguanine‐DNA‐methyltransferase (MGMT) by lomeguatrib reduces multiple myeloma cell viability and impairs DNA repair in MGMT‐proficient cells.

Published in:

Chemical Biology & Drug Design, 2024, v. 103, n. 2, p. 1, doi. 10.1111/cbdd.14465

By:

Akcora‐Yildiz, Dilara;
Ozkan, Tulin;
Cetintav, Bekir;
Yukselten, Yunus;
Calis, Seyma;
Sevim‐Nalkiran, Hatice;
Turkel, Nezaket;
Gunduz, Mehmet;
Ozen, Mehmet;
Beksac, Meral;
Sunguroglu, Asuman

Publication type:

Article

Characterization of MGMT and EGFR protein expression in glioblastoma and association with survival.

Published in:

Journal of Neuro-Oncology, 2020, v. 146, n. 1, p. 163, doi. 10.1007/s11060-019-03358-x

By:

Schaff, Lauren R.;
Yan, Dongyao;
Thyparambil, Sheeno;
Tian, Yuan;
Cecchi, Fabiola;
Rosenblum, Marc;
Reiner, Anne S.;
Panageas, Katherine S.;
Hembrough, Todd;
Lin, Andrew L.

Publication type:

Article

Weak MGMT gene promoter methylation confers a clinically significant survival benefit in patients with newly diagnosed glioblastoma: a retrospective cohort study.

Published in:

Journal of Neuro-Oncology, 2020, v. 146, n. 1, p. 55, doi. 10.1007/s11060-019-03334-5

By:

Pinson, H.;
Hallaert, G.;
Van der Meulen, J.;
Dedeurwaerdere, F.;
Vanhauwaert, D.;
Van den Broecke, C.;
Van Dorpe, J.;
Van Roost, D.;
Kalala, J. P.;
Boterberg, T.

Publication type:

Article

Role of postoperative tumor volume in patients with MGMT-unmethylated glioblastoma.

Published in:

Journal of Neuro-Oncology, 2019, v. 142, n. 3, p. 529, doi. 10.1007/s11060-019-03124-z

By:

Sales, Arthur H. A.;
Bette, Stefanie;
Barz, Melanie;
Huber, Thomas;
Wiestler, Benedikt;
Ryang, Yu-Mi;
Schmidt-Graf, Friederike;
Liesche, Friederike;
Combs, Stephanie E.;
Meyer, Bernhard;
Gempt, Jens

Publication type:

Article

Temporal stability of <italic>MGMT</italic> promoter methylation in glioblastoma patients undergoing STUPP protocol.

Published in:

Journal of Neuro-Oncology, 2018, v. 137, n. 2, p. 233, doi. 10.1007/s11060-017-2722-3

By:

O’Regan, C. J.;
Kearney, H.;
Beausang, A.;
Farrell, M. A.;
Brett, F. M.;
Cryan, J. B.;
Loftus, T. E.;
Buckley, P. G.

Publication type:

Article

MiR-198 enhances temozolomide sensitivity in glioblastoma by targeting MGMT.

Published in:

Journal of Neuro-Oncology, 2017, v. 133, n. 1, p. 59, doi. 10.1007/s11060-017-2425-9

By:

Nie, Er;
Jin, Xin;
Wu, Weining;
Yu, Tianfu;
Zhou, Xu;
Shi, Zhumei;
Zhang, Junxia;
Liu, Ning;
You, Yongping

Publication type:

Article

Defining optimal cutoff value of MGMT promoter methylation by ROC analysis for clinical setting in glioblastoma patients.

Published in:

Journal of Neuro-Oncology, 2017, v. 133, n. 1, p. 193, doi. 10.1007/s11060-017-2433-9

By:

Yuan, Guoqiang;
Niu, Liang;
Zhang, Yinian;
Wang, Xiaoqing;
Ma, Kejun;
Yin, Hang;
Dai, Junqiang;
Zhou, Wangning;
Pan, Yawen

Publication type:

Article